Atlas Trials

Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer

Clinical trial NCT02590003 · TERMINATED

Trial details

NCT number
NCT02590003
Sponsor
Yale University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Carcinoma, Non-small Cell Lung
Start date
2015-11-01
Primary completion
2016-09-01
Enrollment
3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.